J. Kenneth Schoolmeester, II

J. Kenneth Schoolmeester, II, M.D. is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Jacksonville, Florida, specializing in Anatomic Pathology with a focus on gynecologic pathology. He holds board certification in Anatomic Pathology from the American Board of Pathology and has established himself as a leading expert in uterine and ovarian tumors, sarcomas, and molecular pathology.

• Medical College of Virginia (MD)
• Mayo Clinic College of Medicine (Residency in Anatomic Pathology)
• Memorial Sloan Kettering Cancer Center (Fellowship in Oncologic Surgical Pathology)

Dr. Schoolmeester's research spans gynecologic pathology with particular emphasis on soft tissue tumors of the female genital tract, molecular characterization of uterine and ovarian neoplasms, and diagnostic pathology of sarcomas. His work bridges traditional histopathology with cutting-edge molecular techniques to improve diagnostic accuracy and inform treatment approaches. He has made significant contributions to understanding leiomyomas, leiomyosarcomas, and rare gynecologic tumors through detailed clinicopathologic and molecular studies.

Analysis of his recent publications reveals a strong focus on molecular characterization of gynecologic tumors, particularly examining genetic alterations in uterine sarcomas, leiomyomas with unusual features, and rare gynecologic malignancies. His work frequently employs advanced techniques including fluorescence in situ hybridization, next-generation sequencing, and immunohistochemical profiling to characterize tumor biology and improve diagnostic classification.

• Mayo Clinic Fellows' Association Teacher of the Year (2017)
• Arthur Purdy Stout Society Study Award (2012)
• Academic Merit Scholarship from Medical College of Virginia (2006)
• Intersociety Council for Pathology Information Travel Award (2001)

Dr. Schoolmeester actively collaborates with multidisciplinary teams across Mayo Clinic and other institutions, contributing to significant research in gynecologic oncology and molecular pathology. His work has implications for diagnostic classification, risk stratification, and potential therapeutic targets for patients with gynecologic malignancies. He serves as a key resource for diagnostic pathology consultation, particularly for complex gynecologic cases requiring specialized expertise.